TAIEquity · Weekly research terminal

1762

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

TW Healthcare Biotechnology

Latest week
7 Aug 2026
Weekly close
35.75 TWD
Fair value
38.88 TWD
Next-week expectancy
Undecided 48.78%
Weekly Report Chart Pack
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TAI · Equity · Taiwan

1762

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Healthcare Biotechnology

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacturing, and sale of active pharmaceutical ingredients in Taiwan, the United States, India, Greece, Croatia, Japan, and internationally. The company offers antifungal, immunosuppressant, oncology, cardiovascular, peptide drug, immunomodulating agents, statin, muscle relaxant, ACE inhibitor with complete DMF or COS, and other API products. It also provides specialty API immunosuppressants, including mycophenolate mofetil, rapamycin, and tacrolimus; derivative of rapamycin, such as …

Last updated
7 Aug 2026
Exchange
Taiwan Stock Exchange · TAI
Sector
Healthcare
Industry
Biotechnology
Currency
TWD
Market capitalisation
2,695,975,936
Fair value reference
38.88
Next-week expectancy
Undecided · 48.78%
Executive chart read

Over the latest 12 completed weeks ending 2026-08-07, 1762 fell 5.80%, moving from 37.95 to 35.75. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -9.10 and has softened across the 12-week window. Market Dynamics is -0.58 on the latest week. Next-week expectancy is undecided at 48.78% based on similar historical setup states.

Week Ending
7 Aug 2026
Latest Close
35.75
12-Week Change
-5.80%
Trend Signal
Active
Next-Week Expectancy
Undecided 48.78%
Signal Weeks
12 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
7 Aug 2026
Latest Close
35.75
12-Week Change
-5.80%
Trend Signal
Active
Next-Week Expectancy
Undecided 48.78%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
-9.10
Market Dynamics
-0.58

Over the latest 12 completed weeks ending 2026-08-07, 1762 fell 5.80%, moving from 37.95 to 35.75. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -9.10 and has softened across the 12-week window. Market Dynamics is -0.58 on the latest week. Next-week expectancy is undecided at 48.78% based on similar historical setup states.

Industry Peers

Taiwan equities in Biotechnology

Stock Exchange Week Open High Low Close Change
6949 Pell Bio-Med Technology Co., Ltd. TAI 7 Aug 2026 800.00 999.00 799.00 943.00 17.88%
6589 EirGenix Inc. TAI 7 Aug 2026 44.60 48.90 44.30 48.20 8.07%
7827 HanchorBio Inc. TAI 7 Aug 2026 144.50 157.50 144.50 156.00 7.96%
4142 Adimmune Corporation TAI 7 Aug 2026 16.55 17.80 16.45 17.70 6.95%
4178 StemCyte International, Ltd. TAI 7 Aug 2026 17.40 19.00 17.40 18.40 5.75%
6919 CALIWAY BIOPHARMACEUTICALS CO L TAI 7 Aug 2026 102.00 111.00 102.00 105.00 2.94%
6541 Tanvex BioPharma, Inc. TAI 7 Aug 2026 37.10 38.45 36.60 38.05 2.56%
6657 Energenesis Biomedical CO.,LTD. TAI 7 Aug 2026 30.50 31.55 29.40 31.20 2.30%
1733 Apex Biotechnology Corp. TAI 7 Aug 2026 31.30 33.10 30.80 32.00 2.24%
4133 Abnova (Taiwan) Corporation TAI 7 Aug 2026 20.75 21.85 20.75 21.20 2.17%
3164 GenMont Biotech Incorporation TAI 7 Aug 2026 16.25 16.60 16.00 16.40 0.92%
6885 BRIM Biotechnology, Inc. TAI 7 Aug 2026 20.95 21.20 20.50 21.10 0.72%
6550 Polaris Group TAI 7 Aug 2026 11.05 11.35 10.90 11.10 0.45%
1734 Sinphar Pharmaceutical Co.,Ltd. TAI 7 Aug 2026 31.70 31.80 31.30 31.80 0.32%
4169 TCM Biotech International Corp. TAI 7 Aug 2026 158.00 167.50 153.00 157.00 -0.63%
6838 Formosa Pharmaceuticals, Inc. TAI 7 Aug 2026 23.40 23.75 22.80 23.20 -0.85%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context